CEMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Finding the most suitable therapy for each patient poses a challenge due to the clinical and molecular heterogeneity of chronic lymphocytic leukemia
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.